Chief Development Officer · Revolution Medicines, Inc. · Revolution Medicines, Inc. — Stock Option (Right to Buy)
Side
M
Value
—
Shares
6,000
Price
—
Executed
Sep 29, 2026
Disclosed
Oct 1, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 29 executedOct 1, 2026 disclosed
RVMD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · 3.9% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Revolution Medicines, Inc. — Stock Option (Right to Buy)
Ticker
RVMD
Shares
6,000
Price per share
$0
Execution date (reported)
Sep 29, 2026
Owned after transaction
161.3K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
2
What this establishes
Sandler Alan B. filed this Form 4 reporting a option exercise of RVMD on Sep 29, 2026. It became public on Oct 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Development Officer
Sandler Alan B.cik:0001835966
Issuer
Revolution Medicines, Inc.cik:0001628171
Revision history · 0
No field has changed since this record was first ingested.
